149 related articles for article (PubMed ID: 33663192)
1. [Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].
Chen J; Cao YJ; Zhu L; Zhang BL; Liu ZY; Hou HL; Chai YL; Wang P
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(8):597-601. PubMed ID: 33663192
[No Abstract] [Full Text] [Related]
2. Research on the efficacy of cisplatin and nimotuzumab combined with concurrent chemoradiotherapy on locally advanced cervical cancer.
Cao Y; Deng L; Lian S; Jiang Y
J BUON; 2019; 24(5):2013-2019. PubMed ID: 31786869
[TBL] [Abstract][Full Text] [Related]
3. Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.
Lu Y; Chen D; Liang J; Gao J; Luo Z; Wang R; Liu W; Huang C; Ning X; Liu M; Huang H
BMC Cancer; 2019 Dec; 19(1):1262. PubMed ID: 31888551
[TBL] [Abstract][Full Text] [Related]
4. Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study.
Lai X; Gu Q; Zheng X; Liu G; Feng W; Lin X; Mao W
J Cancer Res Ther; 2016 Oct; 12(Supplement):89-95. PubMed ID: 27721263
[TBL] [Abstract][Full Text] [Related]
5. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
Ao M; Li P; Sun D; Li X; Xu S; Hao Y
J Obstet Gynaecol; 2023 Dec; 43(1):2179915. PubMed ID: 37001548
[TBL] [Abstract][Full Text] [Related]
6. A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial.
de Castro Junior G; Segalla JG; de Azevedo SJ; Andrade CJ; Grabarz D; de Araújo Lima França B; Del Giglio A; Lazaretti NS; Álvares MN; Pedrini JL; Kussumoto C; de Matos Neto JN; Forones NM; Fernandes Júnior HJ; Borges G; Girotto G; da Silva IDCG; Maluf-Filho F; Skare NG
Eur J Cancer; 2018 Jan; 88():21-30. PubMed ID: 29179134
[TBL] [Abstract][Full Text] [Related]
7. A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer.
Qi S; Mao Y; Jiang M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1115-1123. PubMed ID: 31502113
[TBL] [Abstract][Full Text] [Related]
8. An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.
Zhang S; Huang X; Zhou L; Wu G; Lin J; Yang S; Chen J; Lin S
J BUON; 2018; 23(6):1656-1661. PubMed ID: 30610791
[TBL] [Abstract][Full Text] [Related]
9. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
10. [A randomized controlled trial of two chemotherapy regimens (paclitaxel liposome combined with platinum and paclitaxel combined with platinum) in concurrent chemoradiotherapy for cervical carcinoma].
Zeng SY; Li L; Zhong ML; Jiang W; Wu YY; Liu Y
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):517-9. PubMed ID: 22093629
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer.
Chen YF; Tang WB; Pan XX; Wu CR; Cao Y; Yang W
Onco Targets Ther; 2017; 10():4113-4119. PubMed ID: 28860820
[TBL] [Abstract][Full Text] [Related]
13. Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Luan W; Yuan H; Hou W; Li J; Liu L
Am J Transl Res; 2022; 14(8):5630-5640. PubMed ID: 36105032
[TBL] [Abstract][Full Text] [Related]
14. Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer.
Jin T; Zhu Y; Luo JL; Zhou N; Li DC; Ju HX; Fan YT; Liu Y; Zhu YP; Feng HY; Liu LY
Int J Colorectal Dis; 2015 Mar; 30(3):337-45. PubMed ID: 25564344
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Ke QH; Zhou SQ; Su XY; Liu Z; Zhang WT; Yang JY
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):629-31. PubMed ID: 22325227
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of icotinib combined with concurrent chemoradiotherapy in locally advanced cervical cancer.
Liu YM; Liu H; Sun HL; Xu YY; Ding Y; Chen WJ; Ying SP
Neoplasma; 2021 May; 68(3):645-651. PubMed ID: 33780264
[TBL] [Abstract][Full Text] [Related]
17. [Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].
Li LF; Wang HQ; Liu XM; Zhang HL; Qiu LH; Qian ZZ; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):626-8. PubMed ID: 22325226
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experience.
Rawat S; Tandan H; Patel S; Chaudhari S
South Asian J Cancer; 2019; 8(1):52-56. PubMed ID: 30766856
[TBL] [Abstract][Full Text] [Related]
19. The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study.
Hu J; Chen Z; Lv J; Zheng Z; Bei Y; Chen X; Zheng L; Song W; Xu Y
Front Oncol; 2022; 12():905422. PubMed ID: 35898885
[TBL] [Abstract][Full Text] [Related]
20. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]